Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Quentin M Anstee

Showing results (151-160 of 261) with videos related to

Pageof 27
Sort By:
Contemporary Clinical Trials|December 28, 2019
Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study designQuentin M Anstee, Brent A Neuschwander-Tetri, Vincent Wai-Sun Wong, et al.
Journal of Hepatology|May 27, 2018
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosisSalvatore Petta, Giada Sebastiani, Elisabetta Bugianesi, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseMarie Boyle, Dina Tiniakos, Jorn M Schattenberg, et al.
Hepatology (Baltimore, Md.)|September 24, 2017
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosisOliver Krenkel, Tobias Puengel, Olivier Govaere, et al.
The New England Journal of Medicine|June 7, 2024
A Phase 2 Randomized Trial of Survodutide in MASH and FibrosisArun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, et al.
Nature Reviews. Gastroenterology & Hepatology|June 26, 2021
Defining comprehensive models of care for NAFLDJeffrey V Lazarus, Quentin M Anstee, Hannes Hagström, et al.
Communications Medicine|July 16, 2024
Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitisElena Sena, Frank Tacke, Quentin M Anstee, et al.
Clinical Science (London, England : 1979)|August 13, 2008
Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissueJeremy F L Cobbold, Quentin M Anstee, Robert D Goldin, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Nature Medicine|September 4, 2012
Multigenerational epigenetic adaptation of the hepatic wound-healing responseMüjdat Zeybel, Timothy Hardy, Yi K Wong, et al.
Pageof 27

Showing results (151-160 of 261) with videos related to

Sort By:
Pageof 27
Contemporary Clinical Trials|December 28, 2019
Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study designQuentin M Anstee, Brent A Neuschwander-Tetri, Vincent Wai-Sun Wong, et al.
Journal of Hepatology|May 27, 2018
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosisSalvatore Petta, Giada Sebastiani, Elisabetta Bugianesi, et al.
JHEP Reports : Innovation in Hepatology|February 11, 2020
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver diseaseMarie Boyle, Dina Tiniakos, Jorn M Schattenberg, et al.
Hepatology (Baltimore, Md.)|September 24, 2017
Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosisOliver Krenkel, Tobias Puengel, Olivier Govaere, et al.
The New England Journal of Medicine|June 7, 2024
A Phase 2 Randomized Trial of Survodutide in MASH and FibrosisArun J Sanyal, Pierre Bedossa, Mandy Fraessdorf, et al.
Nature Reviews. Gastroenterology & Hepatology|June 26, 2021
Defining comprehensive models of care for NAFLDJeffrey V Lazarus, Quentin M Anstee, Hannes Hagström, et al.
Communications Medicine|July 16, 2024
Needs assessment for creation of a platform trial network in metabolic-dysfunction associated steatohepatitisElena Sena, Frank Tacke, Quentin M Anstee, et al.
Clinical Science (London, England : 1979)|August 13, 2008
Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissueJeremy F L Cobbold, Quentin M Anstee, Robert D Goldin, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Nature Medicine|September 4, 2012
Multigenerational epigenetic adaptation of the hepatic wound-healing responseMüjdat Zeybel, Timothy Hardy, Yi K Wong, et al.
Pageof 27